India’s approval of homegrown vaccine criticized over lack of data
over 4 years in nationalpost
NEW DELHI — India on Sunday granted emergency approval to Bharat Biotech’s COVAXIN but faced questions from industry experts and opposition lawmakers after taking the step without publishing efficacy data for the homegrown coronavirus vaccine. The news, announced by the drugs controller general of India (DCGI), was hailed by Prime Minister Narendra Modi and his […]
Who is popular today?
